Pacira (PCRX) BioSciences announced the granting of inducement awards on December 1, 2025 to two new employees under Pacira’s Amended and Restated 2014 Inducement Plan as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the People & Compensation Committee of the Board of Directors without stockholder approval. Two employees received restricted stock units for an aggregate of 2,200 shares of Pacira common stock. Each restricted stock unit represents the contingent right to receive one share of Pacira common stock and the restricted stock unit awards vest annually in four equal installments beginning on December 1, 2026. Vesting of the equity awards is subject to the employee’s continued employment with Pacira. Each equity award is also subject to the terms and conditions of an award agreement.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCRX:
- Pacira announces results from 12-month pilot study on iovera
- Pacira files patent infringement lawsuits against WhiteOak Group and Qilu
- Pacira Pharmaceuticals Faces Revenue Decline Amid Generic Competition and Patent Challenges, Analyst Issues Sell Rating
- Pacira Pharmaceuticals: Positioned for Growth with NOPAIN Act and Innovative Therapies
- Pacira assumed with a Buy at H.C. Wainwright